Generic Ranitidine Manufacturers Claim Plaintiffs Have Not Been Injured
The U.S. Food and Drug Administration (FDA) recalled all Zantac (ranitidine) antacid products from the market on April1, 2020, based on evidence that the products tested positive for unsafe levels of N-nitroso dimethylamine (NDMA), a cancer-causing substance. Since that time, many plaintiffs, who took the medication and were diagnosed with cancer, have filed against the makers of Zantac and...
Continue Reading